Biology Reference
In-Depth Information
Sato T, Foged NT, Delaisse JM (1998) The migration of purified osteoclasts through collagen is
inhibited by matrix metalloproteinase inhibitors. J Bone Miner Res 13:59-66
Satoyoshi E (1992) Therapeutic trials on progressive muscular dystrophy. Intern Med 31:841-846
Schedel J, Seemayer CA, Pap T, Neidhart M, Kuchen S, Michel BA, Gay RE, Muller-
Ladner U, Gay S, Zacharias W (2004) Targeting cathepsin L (CL) by specific ribozymes
decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis. Gene Ther
11:1040-1047
Schonefuss A, Wendt W, Schattling B, Schulten R, Hoffmann K, Stuecker M, Tigges C,
Lubbert H, Stichel C (2009) Upregulation of cathepsin S in psoriatic keratinocytes. Exp
Dermatol
Seftor RE, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, Stetler-Stevenson WG,
Quaranta V, Hendrix MJ (2001) Cooperative interactions of laminin 5 gamma2 chain, matrix
metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry
of embryonic vasculogenesis by aggressive melanoma. Cancer Res 61:6322-6327
Selent J, Kaleta J, Li Z, Lalmanach G, Bromme D (2007) Selective inhibition of the collagenase
activity of cathepsin K. J Biol Chem 282:16492-16501
Serveau-Avesque C, Martino MF, Herve-Grepinet V, Hazouard E, Gauthier F, Diot E, Lalmanach
G (2006) Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage
fluids. Biol Cell 98:15-22
Shapiro SD (1994) Elastolytic metalloproteinases produced by human mononuclear phagocytes.
Potential roles destructive lung disease. Am J Respir Crit Care Med 150:S160-S164
Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA (1992) Molecular cloning and expression
of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem
267:7258-7262
Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman
HA (1999) Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest
104:1191-1197
Shi GP, Bryant RA, Riese R, Verhelst S, Driessen C, Li Z, Bromme D, Ploegh HL, Chapman HA
(2000) Role for cathepsin F in invariant chain processing and major histocompatibility
complex class II peptide loading by macrophages. J Exp Med 191:1177-1186
Shi GP, Sukhova GK, Kuzuya M, Ye Q, Du J, Zhang Y, Pan JH, Lu ML, Cheng XW, Iguchi A,
Perrey S, Lee AM, Chapman HA, Libby P (2003) Deficiency of the cysteine protease cathepsin
S impairs microvessel growth. Circ Res 92:493-500
Silver IA (1975) Measurement of pH and ionic composition of pericellular sites. Philos Trans R
Soc Lond B Biol Sci 271:261-272
Silver IA, Murrills RJ, Etherington DJ (1988) Microelectrode studies on acid microenvironment
beneath adherent macrophages and osteoclasts. Exp Cell Res 175:266-276
Sires UI, Schmid TM, Fliszar CJ, Wang ZQ, Gluck SL, Welgus HG (1995) Complete degradation
of type X collagen requires the combined action of interstitial collagenase and osteoclast-
derived cathepsin B. J Clin Invest 95:2089-2095
Somoza JR, Zhan H, Bowman KK, Yu L, Mortara KD, Palmer JT, Clark JM, McGrath ME (2000)
Crystal structure of human cathepsin V. Biochemistry 39:12543-12551
Somoza JR, Palmer JT, Ho JD (2002) The crystal structure of human cathepsin F and its
implications for the development of novel immunomodulators. J Mol Biol 322:559-568
Srivastava M, Steinwede K, Kiviranta R, Morko J, Hoymann HG, Langer F, Buhling F, Welte T,
Maus UA (2008) Overexpression of cathepsin K in mice decreases collagen deposition and
lung resistance in response to bleomycin-induced pulmonary fibrosis. Respir Res 9:54
Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P (1998) Expression of the elastolytic
cathepsins S and K in human atheroma and regulation of their production in smooth muscle
cells. J Clin Invest 102:576-583
Sukhova GK, Wang B, Libby P, Pan JH, Zhang Y, Grubb A, Fang K, Chapman HA, Shi GP (2005)
Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipopro-
tein E-null mice. Circ Res 96:368-375
